Karin Barchan
Impact in
- Rheumatology top 10%
- Pelvic floor disorders treatments
- Urology top 10%
Papers in
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Anders Malmström (6 shared papers)Gunvor Ekman‐Ordeberg (5 shared papers)U. Ulmsten (3 shared papers)Gunilla Westergren‐Thorsson (2 shared papers)Christian Falconer (2 shared papers)G. Ekman (2 shared papers)Mikael Norman (1 shared paper)Anna Rosén (6 shared papers)
- Journals
- Maturitas (2 papers)Acta Obstetricia Et Gynecologica Scandinavica (2 papers)Protein Engineering Design and Selection (1 paper)Biochemical Journal (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- SwedenNetherlandsUnited Kingdom
In The Last Decade
Karin Barchan
13 papers receiving 334 citations
Peers
Comparison fields: 5 of 52
- Rheumatology 104
- Urology 41
- Immunology 96
- Oncology 104
- Equine 6
Countries citing papers authored by Karin Barchan
This map shows the geographic impact of Karin Barchan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Barchan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Barchan more than expected).
Fields of papers citing papers by Karin Barchan
This network shows the impact of papers produced by Karin Barchan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Barchan. The network helps show where Karin Barchan may publish in the future.
Co-authors
The 25 scholars most cited alongside Karin Barchan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 89 | |
| 2 | 1996 | 77 | |
| 3 | 1996 | 48 | |
| 4 | 1991 | 31 | |
| 5 | 1997 | 30 | |
| 6 | 2002 | 29 | |
| 7 | 2001 | 10 | |
| 8 | 2009 | 10 | |
| 9 | 2023 | 6 | |
| 10 | 2008 | 5 | |
| 11 | 2020 | 4 | |
| 12 | 2001 | 1 | |
| 13 | 2019 | 1 | |
| 14 | 2021 | 0 |
About Karin Barchan
Karin Barchan is a scholar working on Molecular Biology, Immunology, Radiology, Nuclear Medicine and Imaging, Cell Biology and Oncology, having authored 14 papers that have together received 341 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Proteoglycans and glycosaminoglycans research (4 papers), Connective tissue disorders research (3 papers), CAR-T cell therapy research (3 papers), Pregnancy-related medical research (3 papers), Phytoestrogen effects and research (2 papers), Immunotherapy and Immune Responses (2 papers) and Preterm Birth and Chorioamnionitis (2 papers). The work is most often cited by research in Rheumatology (104 citations), Urology (41 citations), Immunology (96 citations), Oncology (104 citations) and Equine (6 citations). Karin Barchan has collaborated with scholars based in Sweden, Netherlands and United Kingdom. Frequent co-authors include Anders Malmström, Gunvor Ekman‐Ordeberg, U. Ulmsten, Gunilla Westergren‐Thorsson, Christian Falconer, G. Ekman, Mikael Norman, Anna Rosén, Peter Ellmark and Laura von Schantz. Their work appears in journals such as Maturitas, Acta Obstetricia Et Gynecologica Scandinavica, Protein Engineering Design and Selection, Biochemical Journal and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.